As American consumers seek relief from soaring medication prices, many are turning to Canada for more affordable options. Despite the benefits of purchasing medications across […]

Alzheimer’s disease has historically been a devastating diagnosis, afflicting millions of people and families around the world. For decades there has been no way to slow the […]

Sprycel (dasatinib), developed by Bristol Myers Squibb, is tyrosine kinase inhibitor approved by the FDA on June 28, 2006, for the treatment of chronic myeloid […]

Attention Americans: Mounjaro, a popular medication for managing type 2 diabetes, has recently launched KwikPens in Canada, adding to the existing vial options. This new […]

The Food and Administration (FDA) has authorized use of Ozempic (semaglutide) for the treatment of chronic kidney disease (CKD) in adults with Type 2 diabetes. This […]